MyoScience raises $10.4M for aesthetic medicine

MyoScience, a stealth-mode medical company based in Redwood City, Calif., has taken $10.4 million in a second funding for continuing clinical trials.

The company has not yet disclosed exactly what use its aesthetic devices will have, although CEO Lisa Elkins hinted that aging eyes and skin might be the target to VentureWire, which first reported the funding.

The funding was led by Nexus Medical Partners, with participation from Accuitive Medical Ventures, De Novo Ventures and Saratoga Ventures. The round is still open.

Next Story: Nanotech chip timing co. Sand 9 raises $8M
Previous Story: Social game creator SGN gets funding from Amazon's Bezos, who looks for more Web hits

Tags: deal